Journal Summary - Discover more summaries and articles from M3 India

Oncology

Choose Topic

[¹⁷⁷Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study

The Lancet Oncology | May 24, 2018 General Oncology Renal/Urologic Radiation Oncology Pharmacology/Therapy

Hemostatic efficacy of pathogen-inactivated- vs untreated- platelets: A randomized controlled trial

Blood | May 24, 2018 Pharmacology/Therapy General Oncology Leukemia/Lymphoma Coagulation/Bleeding Dz

PAM50 and risk of recurrence scores for interval breast cancers

Cancer Prevention Research | May 24, 2018 Gynecologic Oncology Breast Basic Science/Genetics General Oncology Diagnostics/Radiology

Histomorphologic spectrum of germline-related and sporadic BAP-1 Inactivated Melanocytic Tumors

Journal of the American Academy of Dermatology | May 24, 2018 Dermatologic Oncology General Oncology Diagnostics/Radiology

Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Lung Cancer | May 24, 2018 Pharmacology/Therapy Lung/Thoracic Oncology General Oncology

Temporary self-expandable metallic stent placement in post-gastrectomy complications

Gastric Cancer | May 24, 2018 General Oncology GI Oncology Pain Management/Palliative Care

Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease

The Journal of Dermatology | May 24, 2018 General Oncology Pharmacology/Therapy Gynecologic Oncology Dermatologic Oncology

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

OncoTargets and Therapy | May 24, 2018 Gynecologic Oncology General Oncology Diagnostics/Radiology

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: A single-arm, open-label, phase 2 trial

The Lancet Haematology | May 24, 2018 Leukemia/Lymphoma General Oncology Pharmacology/Therapy

Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: Clinical, neurophysiological, functional, and patient-reported outcomes

JAMA Neurology | May 23, 2018 General Oncology Pharmacology/Therapy Peds Heme/Oncology Side Effects

« Prev 1 … 1042 1043 1044 1045 1046 … 1255 Next »

[¹⁷⁷Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study

Hemostatic efficacy of pathogen-inactivated- vs untreated- platelets: A randomized controlled trial

PAM50 and risk of recurrence scores for interval breast cancers

Histomorphologic spectrum of germline-related and sporadic BAP-1 Inactivated Melanocytic Tumors

Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Temporary self-expandable metallic stent placement in post-gastrectomy complications

Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: A single-arm, open-label, phase 2 trial

Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: Clinical, neurophysiological, functional, and patient-reported outcomes

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Fibrate Therapy: Understanding the Risks

Anaesthetic Management in Obese Patients

The Impact of Hormonal Imbalances on Women's Health

Lasers: A Boon in Paediatric Dentistry

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study

Hemostatic efficacy of pathogen-inactivated- vs untreated- platelets: A randomized controlled trial

PAM50 and risk of recurrence scores for interval breast cancers

Histomorphologic spectrum of germline-related and sporadic BAP-1 Inactivated Melanocytic Tumors

Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Temporary self-expandable metallic stent placement in post-gastrectomy complications

Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: A single-arm, open-label, phase 2 trial

Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: Clinical, neurophysiological, functional, and patient-reported outcomes

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Fibrate Therapy: Understanding the Risks

Anaesthetic Management in Obese Patients

The Impact of Hormonal Imbalances on Women's Health

Lasers: A Boon in Paediatric Dentistry

Select Specialty

Select Topic

[¹⁷⁷Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study